Specifications Manual for Joint Commission National Quality Measures (v2020B1)
Posted: 3/30/2020
Home » VTE Present at Admission

Release Notes:
Data Element
Version 2020B1

Name:VTE Present at Admission
Collected For: VTE-6
Definition:Documentation by a physician/APN/PA that VTE was diagnosed or suspected on arrival to the day after admission.
Question:Was there any documentation by the physician/APN/PA that VTE was diagnosed or suspected on arrival to the day after admission?
Format:
Length:1
Type:Alphanumeric
Occurs:1
Allowable Values:

Y (Yes)      There is documentation by the physician/APN/PA that VTE was diagnosed or suspected from hospital arrival to the day after admission.

N (No)      There is no documentation by the physician/APN/PA that VTE was diagnosed or suspected from hospital arrival to the day after admission or unable to determine from medical record documentation.
Notes for Abstraction:
  • The time frame for this data element includes any documentation dated from hospital arrival to the day after admission. It is not necessary to review documentation outside of this time frame to answer this data element.
  • Documentation of suspicion or a diagnosis of a pulmonary embolism (PE) or venous thromboembolism (VTE) in a confirmed location is acceptable. Only accept terms identified in the list of inclusions.
    Note: It is not necessary for a VTE Diagnostic Test to be linked with the physician/APN/PA documented diagnosis of PE or VTE.
    Acceptable Examples:
    • A patient arrived on 10/1/20xx with shortness of breath. On 10/2/20XX, there is physician documentation that a PE is suspected, select “Yes.”
    • Results of a venous Doppler performed the day after admission are positive for VTE in the common femoral vein, select “Yes.”
    • Results of a Doppler are positive for an acute nonocclusive LLE thrombus on the day after admission, select “Yes.”
    • Day of admission physician includes PE on the problem list, select “Yes.”
    • Patient admitted with a diagnosis of left popliteal deep vein thrombus, select “Yes.”
    • Patient arrived on 01/05/20XX with documentation from an outside transferring hospital indicating vascular ultrasound was performed on 01/02/20XX and positive for VTE, select “Yes.”
    • Physician documents in H&P on day of admission, “DVT right lower extremity,” select “Yes.”
      Unacceptable Examples:
    • H&P on day of admission notes that the patient has an occlusion of the subclavian vein. Subclavian vein is not a defined location, select “No.”
    • A patient arrives to the hospital emergency department with C/O severe headache. Differential diagnosis on the day of arrival includes cerebral venous thrombosis (CVT) versus SAH, select “No.”
    • Physician admitting note documents DVT prophylaxis under the treatment plan, select “No.”
    • Patient admitted with a diagnosis of left upper extremity deep vein thrombus, select “No.”
    • Patient has a CT chest with IV contrast on the day of arrival to R/O PE and test results are negative and received by 2359 the day after admission, select “No.”
  • An order for a VTE diagnostic test is acceptable ONLY if it is explicitly documented that VTE/PE is the reason for the test. Only accept terms identified in the list of inclusions. If an acceptable test is ordered for a PE or VTE indication and results are documented as negative by 2359 the day after admission, then suspicion of PE or VTE has been ruled out. Select “No.”
    Acceptable Examples:
    • A patient presents to the hospital emergency department with a chief complaint of pain and swelling in the right calf. A vascular ultrasound of the lower extremities is ordered to R/O DVT, select “Yes” UNLESS results are negative and received by 2359 the day after admission.
    • Bilateral venous Doppler of the lower extremities is ordered on the day after admission for redness and swelling left calf, select “Yes.”
    • A patient arrives on 06/01/20XX. Admitting diagnosis is fever. On 06/02/20XX patient admitted and physician documents “if cough continues may require evaluation for PE.” On 06/03/20XX, CTA chest is ordered and positive for PE. Select “Yes.”
      Unacceptable Examples:
    • Physician orders a bilateral lower extremity arterial duplex on the day after admission. Arterial duplex is not an acceptable test. Select "No" for VTE Present on Admission.
    • Patient presents to the emergency room with complaints of pain all over after sustaining a fall. ED MD orders multiple tests including a CT of the chest with IV contrast. ED MD documents fall as the reason for the test. No mention of PE/VTE, select “No.”
    • A patient is admitted after a motor vehicle accident. On arrival, a CT of the abd/pelvis with IV contrast was done to R/O internal injuries. No mention of PE/VTE, select “No.”
    • Bilateral venous Doppler of the lower extremities is ordered on the day of arrival for redness and swelling left calf. Results returned the same day document no acute VTE in left common femoral vein or popliteal vein, select “No.”
  • Patients who are under treatment and receiving anticoagulation therapy for PE/VTE at the time of hospital arrival, select “Yes.”
    Examples:
    • Patient admitted 04/30/20XX. Physician documents on 04/30/20XX that Coumadin was started on 04/20/20XX for a recently diagnosed PE, select “Yes.”
    • Patient presents with a documented diagnosis of PE on the day of arrival. Coumadin placed on hold to evaluate for GI bleed, select “Yes.”
  • Patients on anticoagulation therapy for another condition (e.g., atrial fibrillation, mitral valve replacement) at the time of hospital arrival, select “Yes.”
    Examples:
    • Patient with a history of stroke and taking dabigatran as a home medication prior to arrival, select “YES.”
    • H&P documents chronic VTE. Taking Coumadin, select “Yes.”
      EXCEPTION:
      Patient on apixaban prior to arrival for a history of atrial fibrillation. Apixaban discontinued on arrival for surgery the day after admission, select “No”.
  • For patients with only a past history of VTE documented, select “No.”
    Example:
    • Problem list includes PE 199X, select “No.”
  • Recurrent, chronic, sub-acute, indeterminate age, select “No,” unless there is also documentation of an acute or new VTE.
  • If the patient was admitted and had surgery on day of or day after hospital admission or ICU admission and there was no documentation of diagnosed/suspected VTE prior to surgery, the VTE is not considered present on admission. Select “No.”
  • Disregard diagnostic procedures performed, e.g., cardiac catheterization, endoscopy, ERCP.
Suggested Data Sources: PHYSICIAN/APN/PA DOCUMENTATION ONLY
  • Consultation notes
  • Discharge summary
  • Emergency Department record
  • History and physical
  • Radiology report
  • Observation notes
  • Outpatient surgery notes
  • Physician notes
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
THIS LIST IS ALL INCLUSIVE VTE Location VTE Confirmed is defined as: Pulmonary Emboli (PE), pulmonary artery embolism, pulmonary trunk embolism, saddle embolism Or DVT Located in:
  • Common femoral vein
  • Common Iliac
  • External Iliac vein
  • Femoral/superficial femoral vein
  • Inferior vena cava (IVC)
  • Infrarenal IVC
  • Intrahepatic IVC
  • Internal iliac
  • Popliteal vein
  • Profunda / deep femoral vein
  • Saphenofemoral junction WITH extension into the common femoral vein
  • Tumor thrombus in the IVC or another defined location
VTE Diagnostic test:
THIS LIST IS ALL INCLUSIVE
  • Compression Ultrasound of lower extremities
  • Venous Ultrasound of lower extremities
  • Duplex Ultrasound (DUS) of lower extremities
  • Venous Doppler of lower extremities
  • Vascular vein mapping of the lower extremities
  • Computed tomography angiography (CTA) / Angiogram of Chest
  • Computed tomography angiography (CTA) / Pulmonary Angiogram of Chest
  • Computed tomography (CT) of thorax (chest) with IV contrast
  • Computed tomography angiography (CTA) / Angiogram of the abdomen
  • Computed tomography (CT) of the abdomen/abdominal aorta with IV contrast
  • Computed tomography (CT) of the pelvis with IV contrast
  • Computed tomography angiography (CTA) / Angiogram of the pelvis
  • Computed tomography (CT) of the lower extremity leg veins with IV contrast
  • CT pulmonary angiogram (CTPA) / CTPA Scan / CT pulmonary embolism (CTPE)
  • Magnetic resonance imaging (MRI or MRV) of the thorax (chest, cardiac)
  • Magnetic resonance imaging (MRI or MRV) of the abdomen
  • Magnetic resonance imaging (MRI or MRV) of the pelvis
  • Magnetic resonance imaging (MRI or MRV) of the lower extremity leg veins
  • Nuclear Medicine Pulmonary Scan/ventilation/perfusion (V/Q) lung scan
  • Pulmonary arteriography/angiography/angiogram
  • Cavagram/cavogram
  • Inferior venocavagram
  • Venography/Venogram of pelvis using IV contrast material
  • Venography/Venogram of femoral using IV contrast material
  • Venography/Venogram of other lower extremity veins using IV contrast material

Refer to Appendix H, Table 2.7 Anticoagulation Therapy for a list of acceptable anticoagulant medications
VTE Confirmed:
  • History of PE or VTE without documentation of a new/acute event
  • VTE not in a defined location
  • Chronic thromboembolic pulmonary hypertension (CTEPH)

VTE Diagnostic Test: Patients with PE or VTE diagnosed by tests not listed

VTE Present at Admission
CPT® only copyright 2019 American Medical Association. All rights reserved.
Specifications Manual for Joint Commission National Quality Measures (v2020B1)
Discharges 07-01-20 (3Q20) through 12-31-20 (4Q20)

LICENSE FOR USE OF CURRENT PROCEDURAL TERMINOLOGY, FOURTH EDITION (“CPT®”)

CPT® only copyright 2019 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.

You, your employees and agents are authorized to use CPT® only as contained in The Joint Commission performance measures solely for your own personal use in directly participating in healthcare programs administered by The Joint Commission. You acknowledge that the American Medical Association (“AMA”) holds all copyright, trademark and other rights in CPT®.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT® for resale and/or license, transferring copies of CPT® to any party not bound by this Agreement, creating any modified or derivative work of CPT®, or making any commercial use of CPT®. License to use CPT® for any use not authorized herein must be obtained through the American Medical Association, Intellectual Property Services, AMA Plaza, 330 North Wabash Avenue, Suite 39300, Chicago, Illinois 60611-5885. Applications are available at the American Medical Association Web site, www.ama- assn.org/go/cpt.

U.S. Government Rights This product includes CPT® which is commercial technical data, which was developed exclusively at private expense by the American Medical Association, 330 North Wabash Avenue, Chicago, Illinois 60611. The American Medical Association does not agree to license CPT® to the Federal Government based on the license in FAR 52.227-14 (Data Rights - General) and DFARS 252.227-7015 (Technical Data - Commercial Items) or any other license provision. The American Medical Association reserves all rights to approve any license with any Federal agency.

Disclaimer of Warranties and Liabilities. CPT® is provided “as is” without warranty of any kind, either expressed or implied, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the (AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this product is with The Joint Commission, and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this product.

This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled “accept”.

^